Anzeige
Mehr »
Dienstag, 10.02.2026 - Börsentäglich über 12.000 News
Goldman sieht 15.000 USD bei Kupfer - dieser Explorer ist noch völlig unbekannt
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
GlobeNewswire (Europe)
474 Leser
Artikel bewerten:
(2)

Imprivata expands commitment to NHS organisations through Identity Governance integration with NHSmail, reducing manual workloads and improving clinical efficiency

Imprivata Identity Governance integrates with NHSmail to reduce manual burdens and streamline identity and access management processes, expanding Imprivata's continued partnership with NHS organisations.

LONDON, Oct. 04, 2023now supports the provisioning of NHSmail accounts in the NHS England shared central tenant to reduce manual and repetitive workloads when on- and off-boarding staff. This integration expands Imprivata's continued commitment to address the critical challenges of frontline staff at NHS organisations. This new capability allows organisations to fully manage the NHSmail account lifecycle, effectively reducing manual workloads by transforming the way NHS organisations manage identity and access controls.

"Safeguarding PHI, complying with regulations, and managing access to critical systems is challenging -to say the least- with manual workflows and processes," said Mark McArdle, Imprivata Chief Products and Design Officer. "We deeply understand the complexities of the NHS. This integration with the NHSmail shared tenant represents a significant milestone in our commitment to both the NHS and our customers by alleviating manual burdens and enabling healthcare workers to focus on providing secure and efficient patient care."

Our long history of working in partnership with NHS organisations has allowed us to develop solutions tailored to the critical needs of frontline NHS workers. This integration builds on existing Imprivata solutions such as the NHS Spine Virtual Smartcard which removes the need for physical smartcards and expensive hardware. Imprivata has also developed solutions that integrate with key clinical NHS systems and applications for electronic prescribing and medicines administration (ePMA). This integration with NHSmail furthers our commitment to and partnership with NHS organisations.

NHSmail is the national email and collaboration service for health and social care in England, enabling NHS staff and clinicians to share information securely and collaborate with other health and care practitioners. Over one millionNHS users in England rely on NHSmail daily to support their initiatives in the delivery of patient care. This integration with the NHSmail shared central tenant allows organisations to fully manage the NHSmail account lifecycle, from account provisioning through account updates to eventual account expiry.

Identity Governance has already been deployed to many NHS organisations for provisioning from the NHS ESR and other data sources into Active Directory, the electronic health record (EHR), and clinical applications. Identity Governance also enables organisations to create NHS email in private Microsoft Office 365 tenants. Other capabilities include:

  • Automate control of new records being added for NHSmail provisioning
  • Eliminate excessive IT resources spent on tedious governance tasks
  • Provide fast and efficient same-day access to NHSmail and require verification during provisioning
  • Govern the identity and access lifecycle to control the entire process of access for joiners, movers, and leavers
  • Enable approval workflows that validate key access assignment prior to automatic provisioning
  • Certify active users to ensure appropriate access is verified on a regular basis
  • Utilise auditing and compliance tools to gain visibility and ensure the right users have all necessary access privileges
  • Reduce human error with automated processes that efficiently improve security by automating manual tasks and proving compliance through reports of those automated processes

To learn more about Imprivata's integration with NHSmail and how it can benefit your organization, read this blog or request a demo.

About Imprivata
Imprivata is the digital identity company for life- and mission-critical industries, redefining how organisations solve complex workflow, security, and compliance challenges with solutions that protect critical data and applications without workflow disruption. Its platform of interoperable identity, authentication, and access management solutions enable organisations in over 45 countries to fully manage and secure all enterprise and third-party digital identities by establishing trust between people, technology, and information. For more information, visit www.imprivata.co.uk.

Media Contact

press@imprivata.com


© 2023 GlobeNewswire (Europe)
Vorsicht, geheim!
2026 startet mit einem Paukenschlag: Der DAX outperformt den US-Markt, Nachzügler holen auf. Ein erstes Signal, dass der Bullenmarkt an Breite gewinnt. Während viele Anleger weiter auf die großen Tech-Namen setzen, hat sich im Hintergrund längst ein Umschwung vollzogen. Der Fokus verschiebt sich weg von überteuerten KI-Highflyern hin zu soliden Qualitätswerten aus der zweiten Reihe.

Anleger, die jetzt clever agieren, setzen nicht auf das, was war, sondern auf das, was kommt. Unternehmen mit gesunder Bilanz, unterschätztem Potenzial und begrenztem Abwärtsrisiko könnten 2026 zu den großen Gewinnern zählen. Die Gefahr einer schärferen Korrektur bleibt real, gerade für passiv aufgestellte Investoren.

In unserem neuen Spezialreport stellen wir fünf Aktien vor, die genau jetzt das Potenzial für überdurchschnittliche Renditen bieten. Stark, günstig und bislang kaum im Fokus.

Jetzt kostenlosen Report herunterladen – bevor es andere tun!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.